Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 388, Issue 16, Pages 1478-1490
Publisher
Massachusetts Medical Society
Online
2023-03-07
DOI
10.1056/nejmoa2213558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling
- (2022) Patrick Andre et al. Frontiers in Medicine
- Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
- (2022) Marius M. Hoeper et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
- (2022) Sachindra R. Joshi et al. Scientific Reports
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2022) Marc Humbert et al. EUROPEAN HEART JOURNAL
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2022) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
- (2022) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Sotatercept for the Treatment of Pulmonary Arterial Hypertension
- (2021) Marc Humbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
- (2021) Gusty R. T. Ryanto et al. Nature Communications
- Temporal trends in pulmonary arterial hypertension: Results from the COMPERA registry
- (2021) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary Arterial Hypertension
- (2021) Paul M. Hassoun NEW ENGLAND JOURNAL OF MEDICINE
- ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
- (2020) Lai-Ming Yung et al. Science Translational Medicine
- Targeting Transforming Growth Factor Beta Receptors in Pulmonary Hypertension
- (2020) Christophe Guignabert et al. EUROPEAN RESPIRATORY JOURNAL
- Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire
- (2018) Kelly M. Chin et al. CHEST
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
- (2017) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans
- (2017) Johannes J. M. van Delden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Selexipag for the Treatment of Pulmonary Arterial Hypertension
- (2015) Olivier Sitbon et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation